Seth Reno

Seth Reno serves as the President and CEO of Arkayli Biopharma, Inc., where the focus is on developing innovative medications with precision drug delivery systems for vascular anomalies. In addition to this role, Seth operates as the Principal at Reno Consulting, LLC, advising life science companies on commercial strategy and operational efficiency. Previous positions include serving as a Commercial Advisor at NeuroBo Pharmaceuticals, Chief Commercial Officer at Gemphire Therapeutics, and various roles at AstraZeneca and MedImmune, notably leading teams in commercial operations and market insights. Seth holds a Bachelor of Science in Human Resources from the University of Delaware and an MBA from Strayer University.